Cargando…

Non-pharmacological treatment-related changes of molecular biomarkers in major depressive disorder: A systematic review and meta-analysis

BACKGROUND: Major depressive disorder (MDD) is a serious mood disorder and leading cause of disability. Despite treatment advances, approximately 30% of individuals with MDD do not achieve adequate clinical response. Better understanding the biological mechanism(s) underlying clinical response to sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Irwin, Courtney L., Coelho, Patrícia S., Kluwe-Schiavon, Bruno, Silva-Fernandes, Anabela, Gonçalves, Óscar F., Leite, Jorge, Carvalho, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asociacion Espanola de Psicologia Conductual 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883286/ https://www.ncbi.nlm.nih.gov/pubmed/36762034 http://dx.doi.org/10.1016/j.ijchp.2023.100367

Ejemplares similares

The Acute Impact of the Early Stages of COVID-19 Pandemic in People with Pre-Existing Psychiatric Disorders: A Systematic Review
por: Carvalho, Sandra, et al.
Publicado: (2022)

The psychological impact of the COVID-19 pandemic in Portugal: The role of personality traits and emotion regulation strategies
por: Kluwe-Schiavon, Bruno, et al.
Publicado: (2022)

Correction: The psychological impact of the COVID-19 pandemic in Portugal: The role of personality traits and emotion regulation strategies
por: Kluwe-Schiavon, Bruno, et al.
Publicado: (2023)

Transcranial Direct Current Stimulation as an Add-on Treatment to Cognitive-Behavior Therapy in First Episode Drug-Naïve Major Depression Patients: The ESAP Study Protocol
por: Carvalho, Sandra, et al.
Publicado: (2020)

Potential biomarkers of major depression diagnosis and chronicity
por: Galvão, Ana Cecília de Menezes, et al.
Publicado: (2021)

Pharmacological Treatment of Major Depressive Disorder in Adolescents
por: Farley, Rachel L.
Publicado: (2005)

Validation of the Brazilian Portuguese version of the Quick Inventory of Depressive Symptomatology and Self-Report (QIDS-SR(16)) for the Brazilian population
por: Bandinelli, Lucas, et al.
Publicado: (2023)

Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews
por: Gartlehner, Gerald, et al.
Publicado: (2017)

To produce or not to produce? Contrasting the effect of substance abuse in social decision-making situations
por: Avila-Chauvet, Laurent, et al.
Publicado: (2023)

Major depressive disorder in detention officers
por: Santos, Sheila Nascimento, et al.
Publicado: (2021)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez, Enric, et al.
Publicado: (2014)

Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
por: Young, Juan Joseph, et al.
Publicado: (2016)

MicroRNAs as Critical Biomarkers of Major Depressive Disorder: A Comprehensive Perspective
por: Ortega, Miguel A., et al.
Publicado: (2021)

Dysregulation of the Lateral Habenula in Major Depressive Disorder
por: Browne, Caroline A., et al.
Publicado: (2018)

Identifying circulating biomarkers for major depressive disorder
por: Zhang, En, et al.
Publicado: (2023)

Program of algorithm for pharmacological treatment of major depressive disorder in China: Benefits or not?
por: Zhu, Yuncheng, et al.
Publicado: (2023)

MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants
por: Cholewinski, Tomasz, et al.
Publicado: (2021)

Speed of Processing (SoP) Training Plus α-tACS in People With Mild Cognitive Impairment: A Double Blind, Parallel, Placebo Controlled Trial Study Protocol
por: Leite, Jorge, et al.
Publicado: (2022)

Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments
por: Maffioletti, Elisabetta, et al.
Publicado: (2020)

Patterns of Default Mode Network Deactivation in Obsessive Compulsive Disorder
por: Gonçalves, Óscar F., et al.
Publicado: (2017)

Peripheral Biomarkers in Animal Models of Major Depressive Disorder
por: Carboni, Lucia
Publicado: (2013)

Biomarkers of Major Depressive Disorder: Knowing is Half the Battle
por: Malik, Sahil, et al.
Publicado: (2021)

Predictive Biomarkers of Treatment Response in Major Depressive Disorder
por: Stolz, Louise A., et al.
Publicado: (2023)

Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy
por: Demir, Süleyman, et al.
Publicado: (2015)

Network Pharmacology-Based and Experimental Identification of the Effects of Paeoniflorin on Major Depressive Disorder
por: Zhang, Sha, et al.
Publicado: (2022)

Mechanism of saikogenin G against major depressive disorder determined by network pharmacology
por: Hu, Lili, et al.
Publicado: (2022)

Task-Specific Effects of tDCS-Induced Cortical Excitability Changes on Cognitive and Motor Sequence Set Shifting Performance
por: Leite, Jorge, et al.
Publicado: (2011)

Endemic Plant Species Conservation: Biotechnological Approaches
por: Coelho, Natacha, et al.
Publicado: (2020)

Major depressive disorder in children and adolescents
por: Mullen, Sandra
Publicado: (2018)

Neurobiological and pharmacological arguments for customization of cognitive behavioral psychotherapy in the treatment of major depressive disorder
por: Ristea, Silvia, et al.
Publicado: (2021)

The effectiveness of electroconvulsive therapy in substance use disorder at pharmacological treatment failure major depression
por: Dannon, P.
Publicado: (2023)

Neuroimaging-based biomarkers for treatment selection in major depressive disorder
por: Dunlop, Boadie W., et al.
Publicado: (2014)

Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder
por: Leuchter, Andrew F., et al.
Publicado: (2014)

Metabolic and Microbiota Measures as Peripheral Biomarkers in Major Depressive Disorder
por: Horne, Rachael, et al.
Publicado: (2018)

C-Reactive Protein as a Biomarker for Major Depressive Disorder?
por: Orsolini, Laura, et al.
Publicado: (2022)

The Role of Lipid Biomarkers in Major Depression
por: Parekh, Amy, et al.
Publicado: (2017)

Correction: Psychophysiological Correlates of Sexually and Non-Sexually Motivated Attention to Film Clips in a Workload Task
por: Carvalho, Sandra, et al.
Publicado: (2012)

Psychophysiological Correlates of Sexually and Non-Sexually Motivated Attention to Film Clips in a Workload Task
por: Carvalho, Sandra, et al.
Publicado: (2011)

Cocaine use disorder in females is associated with altered social decision-making: a study with the prisoner’s dilemma and the ultimatum game
por: Viola, Thiago Wendt, et al.
Publicado: (2019)

Editorial: Polysubstance Abuse and Cognitive Dysfunction
por: Kluwe-Schiavon, Bruno, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tvh1j91ucte9g99nkij3evb60e